Popular Modules & Bundles

This course is designed to equip pharmacist professionals with the knowledge and skills necessary to navigate Australia's evolving medical cannabis landscape. Designed for pharmacists, this course will help you gain essential knowledge for safely and effectively handling medical cannabis. Develop a practical understanding of the endocannabinoid system, crucial for dispensing, monitoring, and adjusting cannabinoid medications within Australia's regulations. Understand your distinct role as a pharmacist in patient care, and learn to lead discussions with your patients for their best health outcomes. Join a cohort of passionate pharmacists in Australia who have chosen to broaden their skills in medical cannabis prescribing. With this course, you can be part of improving treatment options for patients suffering from chronic conditions Australia wide.  Preview this course by watching the video above. Estimated Duration: 8 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Discuss the individual components of the cannabis plant Describe cannabis medicine options accurately Explain how the endocannabinoid system functions Assess the suitability of cannabis treatment for various chronic disease states Identify appropriate and inappropriate patient cohorts for medical cannabis treatment Discuss with patients about medical cannabis as a therapeutic option for symptom management Describe how to initiate, monitor and titrate cannabinoid medicines Apply critical safety considerations in patient-centred care Describe the role and responsibilities of pharmacists in relation to medical cannabis therapy Explain how pharmacists can educate patients on safe and effective use of medical cannabis Discuss how to collaborate with other healthcare providers to monitor patient outcomes and adjust treatment plans Describe requirements for storing medical cannabis Discuss quality control measures for medical cannabis products Explain the Australian regulatory frameworks surrounding medical cannabis provision Claim 17 CPD credits for eligible participants.

This accredited course provides doctors with a comprehensive introduction to the clinical and regulatory foundations of medical cannabis prescribing in Australia. As patient interest in cannabinoid-based therapies increases, it is essential for prescribers to be equipped with evidence-informed knowledge and practical skills to navigate this evolving space safely and effectively. Through this program, participants will explore the endocannabinoid system and its relevance to human physiology, examine the pharmacology of key cannabis constituents, and gain practical insight into initiating, monitoring, and titrating medical cannabis products. The course also addresses the Australian regulatory landscape and offers guidance on assessing patient suitability, facilitating informed discussions, and applying critical safety considerations in clinical practice. Designed to support evidence-based decision-making, this course empowers doctors to responsibly consider medical cannabis as part of a broader, patient-centred approach to managing chronic symptoms and conditions. Preview this course by watching the video above. Estimated Duration: 5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe cannabis medicines accurately and demonstrate an understanding of the individual chemical components of the plant. Demonstrate an understanding of endocannabinoid system function. Assess the suitability of cannabis treatments in various chronic disease states. Identify appropriate patient cohorts for medical cannabis treatment. Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management. Initiate, monitor and titrate cannabinoid medicines.  Apply critical safety considerations in patient-centred care. Navigate the regulatory frameworks surrounding medical cannabis provision in Australia. 

This course is designed to equip nursing professionals with the knowledge and skills necessary to navigate Australia's evolving medical cannabis landscape. DEVELOPER'S NOTE: As nurses, we understand the growing importance of holistic care and the role medical cannabis can have in managing a multitude of conditions. Join us in this meticulously crafted course to explore the history and botany of cannabis, understand the role of the endocannabinoid system and homeostasis. Learn how to navigate TGA processes, monitor and manage potential adverse side effects and other important aspects of cannabis treatment and patient care. This course is created and endorsed by nurses who believe in the potential of medical cannabis as a vital component of integrative, modern healthcare. Preview this course by watching the video above. Estimated Duration: 5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe cannabis medicines accurately and demonstrate an understanding of the individual chemical components of the plant. Demonstrate an understanding of endocannabinoid system function. Assess the suitability of cannabis treatments in various chronic disease states. Identify appropriate patient cohorts for medical cannabis treatment. Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management. Monitor and provide titration advice around cannabinoid medicines.  Apply critical safety considerations in patient centred care. Navigate the regulatory frameworks surrounding medical cannabis provision in Australia.  Claim 5 CPD hours for eligible participants.

This module explores the endocannabinoid system (ECS) and its critical role in the effects of medical cannabis. It examines the discoveries that shaped our understanding of the ECS, its primary components—such as CB1, CB2, and TRPV1 receptors—and the mechanisms of retrograde cell signaling, which underpins how cannabinoids influence physiological processes. Participants will learn about the role of ECS ligands and non-ligand mediators in cannabis pharmacology, the concept of endocannabinoid tone, and factors that can affect it. Clinical considerations are addressed to provide a deeper understanding of how the ECS informs the safe and effective use of medical cannabis in patient care. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe the discoveries that shaped today's understanding of the endocannabinoid system (ECS) Explain the functions of the ECS, its main components, and how they interact Discuss the function and benefits of retrograde cell signalling Outline the roles and functions of cannabinoid receptors CB1 and CB2, and vanilloid receptor TRPV1 Identify ECS ligands and non-ligand mediators and describe their role in ECS function Define endocannabinoid tone and its influencing factors Discuss clinical considerations related to the ECS

This microcredential offers healthcare professionals a comprehensive overview of medical cannabis, its pharmacological properties, and treatment options. Through a series of focussed modules, learners will gain a deep understanding of how cannabis interacts with the endocannabinoid system and its therapeutic potential.Modules Include: The Endocannabinoid System and Medical Cannabis – An Introduction Explore the foundational science behind medical cannabis and its interaction with the human body's endocannabinoid system. Understand key mechanisms of action that make cannabis a unique treatment option. Medical Cannabis Taxonomy, Genetics, Strains, and Compounds Delve into the biological diversity of cannabis. Learn about the taxonomy, genetics, and various strains, and examine the wide range of cannabinoids and terpenes that influence its therapeutic effects. Introduction to Medical Cannabis Products Gain an essential overview of medical cannabis products, covering their categorisation, administration methods, and key components like THC and CBD, including factors influencing the safety and efficacy of medical cannabis products, such as speed of onset, bioavailability, and duration of effects. Preview this module by watching the video above. Estimated Duration: 3 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this microcredential, you’ll be able to: Describe the discoveries that shaped today's understanding of the endocannabinoid system (ECS) Explain the functions of the ECS, its main components, and how they interact Discuss the function and benefits of retrograde cell signalling Outline the roles and functions of cannabinoid receptors CB1 and CB2, and vanilloid receptor TRPV1 Identify ECS ligands and non-ligand mediators and describe their role in ECS function Define endocannabinoid tone and its influencing factors Discuss clinical considerations related to the ECS Identify cannabis' taxonomic status Identify and discuss key components of strains and chemovars Identify key compounds in medical cannabis and explain their potential interactions and effects within the body Describe the factors that impact medical cannabis' effects within the body Explain how practitioners may adjust medical cannabis treatment to account for clinical and individual factors, risks and contraindications Define endogenous and exogenous cannabinoids Describe the properties of THC and CBD, including their potential therapeutic and medicinal effects Describe different medical cannabis product categorisations Identify, for different administration methods, speed of onset, bioavailability and duration of effects Explain considerations when selecting medical cannabis products to improve safety and efficacy for patients

This microcredential offers healthcare professionals an in-depth look at how medical cannabis can be integrated into the management of chronic pain in complex patient cases. Through real-world scenarios, this microcredential highlights the therapeutic potential of cannabis while addressing concerns related to coexisting conditions, medication interactions, and patient quality of life. This microcredential includes: Clinical Case Study - ADHD Symptoms and Chronic Pain: Explore how medical cannabis helped Hayley, a 37-year-old patient with combined-type ADHD and chronic pain, manage her attention, anxiety, sleep, and physical discomfort. Clinical Case Study - Chronic Pain & Hepatic Dysfunction: Follow Stephen, a 56-year-old with hepatic fibrosis, as his healthcare team safely incorporated medical cannabis into his treatment plan for chronic back pain and gout, restoring his active lifestyle. Clinical Case Study - Chronic Pain, Insomnia & Cardiac Issues: Delve into Jen’s case, a 60-year-old with complex regional pain syndrome and stable cardiovascular disease, who found relief from chronic pain and insomnia through carefully managed medical cannabis treatment. Clinical Case Study - MS-Associated Chronic Pain and Spasticity: Examine how Johanna, a 39-year-old with multiple sclerosis, addressed her neuropathic pain and spasticity using an affordable, well-balanced cannabis treatment plan, overcoming challenges related to her other medications and financial constraints. This microcredential is designed to enhance practitioners’ understanding of medical cannabis' role in improving patient outcomes in chronic pain management, even in complex clinical scenarios. Preview this module by watching the video above. Estimated Duration: 4 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Demonstrate an understanding of the role of medical cannabis in managing chronic pain in patients with coexisting conditions like ADHD, hepatic dysfunction, cardiac issues, and multiple sclerosis. Evaluate real-world case studies to assess cannabis' therapeutic potential for symptom management. Apply critical safety considerations and risk mitigation strategies for patients with hepatic and cardiac concerns. Discuss potential drug-drug interactions and the safe use of medical cannabis in complex patient cases. Facilitate patient-centered discussions around medical cannabis for chronic pain, addressing sleep and psychological symptoms. Devise tailored cannabis treatment plans that consider patient safety, minimise risk, and enhance quality of life in complex cases.

This module provides healthcare practitioners with a foundational understanding of mental health conditions, focussing on their prevalence, underlying mechanisms, and clinical impact—particularly in the Australian context. By examining the characteristics and pathophysiology of common conditions, practitioners will better understand current treatment limitations and the growing interest in alternative or adjunctive options such as medical cannabis.The module explores the potential mechanisms through which medical cannabis may alleviate specific symptoms associated with mental health conditions, while also addressing the limitations and risks of its use in this context. Evidence-based strategies for risk mitigation and safe prescribing are presented to support informed, patient-centred decision-making.Upon completion, practitioners will be better equipped to evaluate the appropriate role of medical cannabis in mental health care and to integrate it safely and effectively into treatment plans where clinically appropriate. Preview this module by watching the video above. Estimated Duration: 1 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Define mental health and mental health conditions Explain the prevalence and impact of mental health issues in Australia Identify key risk factors for developing mental health conditions in Australia Describe the characteristics, pathophysiology, and treatment options for common mental health conditions Explain how medical cannabis may alleviate symptoms of mental health conditions through its primary mechanisms of action Describe the therapeutic potential of medical cannabis for treating symptoms of common mental health conditions Outline potential risks of medical cannabis treatment for mental health symptoms and discuss risk management strategies where appropriate

This module explores the complexities of chronic pain and its management, with a focus on the potential role of medical cannabis. Learners will examine the factors influencing pain perception, the mechanisms of pain signaling, and the different aetiologies and pathophysiologies of pain. The module addresses the interplay between physical and psychosocial factors in the pain experience and the impacts of chronic pain on individuals and the Australian healthcare system. It also covers common treatment interventions, the therapeutic potential of medical cannabis for chronic pain and co-occurring conditions, and considerations for its use. Healthcare practitioners will gain insights into addressing barriers to medical cannabis treatment to support improved patient outcomes. Preview this module by watching the video above. Estimated Duration: 1 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Identify the factors that affect an individual's experience of pain Explain the pain signalling process Identify different pain aetiologies and pathophysiologies Explain the interplay between physical and psychosocial factors in the pain experience Define chronic pain and explain its impacts on individuals and the Australian healthcare and social support systems Describe common treatment interventions for chronic pain Describe medical cannabis' therapeutic potential for treating chronic pain and common co-occurring conditions Identify general considerations for medical cannabis treatment Explain common barriers to medical cannabis treatment and how to address them

This module provides healthcare practitioners with a comprehensive understanding of the biological components of medical cannabis and their therapeutic potential. As cannabis becomes more widely accepted, it's essential to grasp how its taxonomy, strains, chemovars, and key compounds interact within the body to provide treatment benefits. Through this module, practitioners will learn how to identify cannabis' taxonomic status, discuss the key components of strains, and explain how cannabinoids and terpenes affect the body. You'll also explore the factors that influence cannabis' effects and how practitioners can adjust treatment to account for clinical and individual patient factors, risks, and contraindications. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Identify cannabis' taxonomic status Identify and discuss key components of strains and chemovars Identify key compounds in medical cannabis and explain their potential interactions and effects within the body Describe the factors that impact medical cannabis' effects within the body Explain how practitioners may adjust medical cannabis treatment to account for clinical and individual factors, risks and contraindications

Sixty-year-old Jen was hesitant when she walked into the consultation room. She had been experiencing severe ankle pain caused by chronic regional pain syndrome and her treatments to date hadn’t done the trick. But medical cannabis? Wouldn’t she end up walking around “like a zombie”? To complicate matters further, Jen has a history of now-stable cardiovascular disease. THC and CBD can affect cardiac functioning and interact with common POAC drugs.  But, all hope was not lost! In this case study, find out how Jen’s team safely treated her pain and secondary insomnia using medical cannabis, and minimised psychotropic effects so she remained her lively, vital self throughout treatment. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the cardiac effects of medical cannabis Discuss the potential benefits and limitations of medical cannabis as a treatment option in patients with cardiac disease Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management Apply critical safety considerations/risk mitigation strategies for patients presenting with cardiac concerns Discuss potential drug-drug interactions Provide medication safety education to patients around drug-drug interactions

In the current landscape, medical cannabis products are tightly regulated with stringent dispensing requirements. Medical cannabis dispensers (MCDs), and the businesses they represent, are responsible for adhering to all relevant legislation and policy while also implementing best practice dispensing for robust patient-centred care. This fundamental module equips pharmacists with the knowledge and skills to effectively fulfil their essential role in dispensing medical cannabis.  Beyond the technical aspects, pharmacists serve as key advocates for patient care, ensuring the safety, privacy, and well-being of patients throughout their medical cannabis journey. In this module, learners will explore methods to build trust with patients, provide comprehensive education on cannabis products, and ensure compliance with record-keeping and reporting standards. This module also emphasises the critical role of collaboration with healthcare teams to ensure safer, more effective treatment outcomes. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Identify the legal and ethical responsibilities of medical cannabis dispensers (MCDs) Implement respectful communication practices to educate and build safety, trust and rapport with patients Counsel patients on safe use of medical cannabis products – including dosage, titration, administration, storage and identifying and responding to side effects Explain how to store, monitor and maintain medical cannabis products securely Discuss pharmacists' record-keeping obligations when dispensing medical cannabis Collaborate with other health practitioners for a multidisciplinary approach to medical cannabis treatment

This module explores the complexities of cancer, including its pathogenesis, common types, grading criteria, and contemporary treatment options. Learners will gain insights into the rising incidence of cancer in Australia and the significant advancements in survival rates, alongside the challenges posed by treatment side effects. A key focus will be the emerging role of medical cannabis, examining its therapeutic potential for alleviating cancer symptoms and mitigating treatment side effects, as well as its implications for palliative care. By the end of the module, learners will be equipped to explain cancer's biological mechanisms, identify various cancers and their treatments, and assess the benefits and risks of medical cannabis in cancer care. This knowledge aims to enhance understanding and support improved patient outcomes in the evolving landscape of cancer treatment. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Explain the pathogenesis and pathophysiology of cancer Identify and describe the main types of cancers and tumours Identify and describe the common cancer-grading criteria Identify and explain contemporary cancer treatments, their benefits, risks and side effects Explain medical cannabis’ therapeutic potential for treating cancer symptoms and treatment side effects Identify risks associated with medical cannabis treatment for those with cancer Explain how medical cannabis may play a role in palliative care for those with cancer

While medical cannabis is an effective treatment option for many patients, it’s considered an unapproved good on the TGA’s schedule of drugs. This course is designed to equip healthcare professionals with the skills, knowledge and confidence to navigate the TGA’s Special Access Scheme (SAS) and apply to prescribe medical cannabis to suitable individual patients on a case by case basis using the SAS-B pathway.  We’ll also delve into the broader legal and ethical considerations of prescribing medical cannabis as a treatment option, including risk-mitigation strategies so you can start prescribing medical cannabis to your eligible patients as soon as possible. Preview this module by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Define unapproved good Describe different pathways for accessing and prescribing unapproved goods Explain the differences and correct use of the SAS and Authorised prescriber pathways Apply to prescribe medical cannabis for individual patients using the SAS-B pathway Explain the legal and ethical considerations, and risk-mitigation strategies when prescribing medical cannabis via the SAS-B pathway

As medicinal cannabis becomes increasingly encountered in clinical practice,1 healthcare professionals are navigating a growing range of products alongside evolving regulatory requirements.2 In this 5-part video series, learn about the different forms of medicinal cannabis products currently available in Australia, including formulations, administration methods, pharmacokinetic and pharmacodynamic profiles and how these factors influence prescribing considerations. Additionally, explore the five categories of medicinal cannabis products relevant to prescribing via the TGA's Special Access Scheme and Authorised Prescriber access pathways. With a focus on foundational understanding and practical implications, this video series is suitable for beginner to intermediate prescribers and those wishing to broaden their understanding of the range of medicinal cannabis products available in Australia today. Estimated Duration: 15 minutes Access Duration: 12 months from date of purchase References Hallinan et al. Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis. BMJ Open. 2021;11:e054044. Martin et al. Exploring access to medicinal cannabis through general practitioners in Australia. Aust J Gen Pract. 2025;54:101–108.